Cme Group INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
CME Group achieved its most successful year in 2025 with record revenue and trading volumes, while proposing significant corporate governance changes to eliminate Class B director election rights.
NASDAQ
Several candidates are seeking election to the CME Group Board of Directors, outlining their qualifications, experience, and goals for the exchange's future.
NASDAQ
CME Group Inc. will hold its annual shareholder meeting on May 8, 2025, where shareholders will vote on the election of directors, ratification of the independent auditor, and executive compensation.
NASDAQ
DEF: CME Group Reports Record Performance in 2024, Driven by Global Uncertainty and Broad-Based Growth
CME Group achieved its best year in history in 2024, with record volume and revenue driven by increased demand for risk management tools amid global uncertainty.
NASDAQ
DEFA14A: CME Group Board Elections: Candidates Campaign for Shareholder Votes Ahead of Annual Meeting
Several candidates are vying for positions on the CME Group Board of Directors, outlining their qualifications and priorities in advance of the upcoming shareholder vote.
NASDAQ
CME Group's 2024 Annual Meeting will be held on May 9, 2024, and shareholders are encouraged to vote on key proposals, including the election of directors and ratification of the company's auditor.
NASDAQ
CME Group achieved its strongest year in history in 2023, driven by escalating economic uncertainties and global demand for its futures and options products.